Anne Krueger

Fighting Post-COVID and ME/CFS – development of curative therapies

F. Knolle, C. Meisel, C. Scheibenbogen, 2023, Frontiers in Medicine.

Mild therapeutic hypothermia shortens intensive care unit stay of survivors after out-of-hospital cardiac arrest compared to historical controls

J. Schefold, M. Oppert, C. Storm, 2008, Critical care.

2-year survival of patients undergoing mild hypothermia treatment after ventricular fibrillation cardiac arrest is significantly improved compared to historical controls

J. Schefold, C. Storm, D. Hasper, 2010, Scandinavian journal of trauma, resuscitation and emergency medicine.

Prehospital cooling with hypothermia caps (PreCoCa): a feasibility study

J. Schefold, W. Schmidbauer, T. Kerner, 2008, Clinical Research in Cardiology.

ResearchMild therapeutic hypothermia alters neuron specific enolase as an outcome predictor after resuscitation : 97 prospective hypothermia patients compared to 133 historical non-hypothermia patients

C. Ploner, J. Schefold, E. Dietz, 2015 .

The Case | A nonhealing skin ulcer in a patient 5 years after successful transplantation.

K. Eckardt, J. Voelkl, U. Hillen, 2021, Kidney international.

Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME

H. Volk, P. Reinke, C. Scheibenbogen, 2018, PloS one.